4 – 6 MAY 2022

3PM – 8PM CEST | 9AM – 2PM EDT

Day 1: Individualising Treatment

Day 2: Complex Phenotypes and Advanced Treatment

Day 3: Beyond Foundational Management


A global virtual event dedicated to the latest heart failure treatment strategies to support better patient outcomes


Radcliffe Cardiology is delighted to introduce Heart Failure Online (HFO) from 4 – 6 May 2022 at 3PM – 8PM CEST / 9AM – 2PM EDT.

Heart Failure Online (HFO) is a new innovative virtual event, that will bring together a leading international faculty to create a rich, interactive experience to best inform the global heart failure community of the latest developments and advances in clinical practice.

With patient management and outcomes at its core, Course Director Prof Andrew Coats (Monash University, Australia, and Warwick University, UK) will lead an interactive programme of discussion, opinion and case studies focusing on the patient journey. By utilising a key theme each day (remove: each day as a key theme), this event will enable multiple aspects of the HF management to be explored by a global faculty, delivering 12 hours of best-in-class learning.

Register for free here to join the experience.


An innovative three-day event:

  • Expert opinion and discussion from international thought-leaders
  • Case studies
  • Audience interaction
  • Best-in-class learning
  • Global faculty
  • 12-hours of CME-accredited learning*

* An application has been submitted to the European Board of Accreditation in Cardiology EBAC for a total of 12 CME points.


Register Now

This live conference starts in:





Prof Andrew Coats


(Please note this programme is subject to change)

DAY 1: Individualising Treatment

4 May | 3 – 8pm CEST | 9am – 2pm EDT

Presentation and Discussion
Case Studies and Device Implantation
Symposia and Technical Breakout Sessions

Register now

DAY 2: Complex Phenotypes and Advanced Treatment

5 May | 3 – 8pm CEST | 9am – 2pm EDT

Presentation and Discussion
Case Studies and Device Implantation
Symposia and Technical Breakout Sessions

Register now

DAY 3: Beyond Foundational Management

6 May | 3 – 8pm CEST | 9am – 2pm EDT

Presentation and Discussion
Case Studies and Device Implantation
Symposia and Technical Breakout Sessions

Register now

Course Leadership

Prof Andrew Coats
Prof Andrew Coats


Director of the Monash Warwick Alliance and Academic Vice-President

Monash University, Australia and University of Warwick, UK

Prof Coats is Joint Academic Vice-President of Monash University, Australia and the University of Warwick, UK. His research greatly influenced the treatment for chronic heart failure, promoting exercise training instead of bed rest. He has a vast experience in education and publishing.

Prof Coats attended Melbourne Grammar School and studied at Oxford and Cambridge. He has a higher doctorates from Oxford (DM) and Imperial (DSc.).

Prof Coats was appointed Viscount Royston Professor of Cardiology at Imperial College in 1996 and Director of Cardiology and Associate Medical Director of the Royal Brompton and Harefield NHS trust. Professor Coats was appointed Dean of Medicine at the University of Sydney in 2002, and subsequently Deputy Vice-Chancellor. Professor Coats was most recently CEO of the Norwich Research Park, the UK's oldest and largest research and innovation park.

Prof Coats research interests are chronic heart failure, hypertension, and organizational behaviour. Professor Coats has a MBA from London Business School, is a Diplomate and Fellow of the Australian Institute of Company Directors and member of the UK Institute of Directors.

More info

Less info

Prof Ilena Piña
Dr Ilena Piña


Wayne State University, Detroit, MI, US

Ileana L Pina, MD, MPH, is Professor, Department of Medicine (Cardiology) and Professor, Department of Epidemiology and Population Health - Montefiore Einstein Center for Heart and Vascular Care, US.
Dr Piña has a particular research and clinical interest in rehabilitation of heart disease in patients with heart failure. She completed a NHLBI HF ACTION trial and is in the process of examining recovery after exercise which could be translated to an additional parameter that may better predict prognosis of outcomes. In addition, there was a R21 to NHLBI to examine Vitamin D levels as another predictor from the HF ACTION database.
Dr Piña was appointed Director of Heart Failure and Transplantation at University Hospitals of Cleveland, a position she held from 1999 to 2006. She further completed a Quality Scholar Fellowship at the Cleveland Louis Stokes Veterans’ Administration Medical Center. In July 2011, she joined the Montefiore Einstein Center for Heart and Vascular Care as Associate Chief for Academic Affairs and Staff Physician.
Dr Ileana L Pina is an Editorial Board member of Cardiac Failure Review.

More info

Less info

Dr Shelley Zieroth
Dr Shelley Zieroth


University of Manitoba, Canada

Dr Shelley Zieroth is currently at SBH Heart Failure and Transplant Clinics and serves as Head of the Medical Heart Failure Program, WRHA Cardiac Sciences Program, and as Associate Professor of the Section of Cardiology at the University of Manitoba, Canada.
Dr Shelley Zieroth is an Editorial Board member of Cardiac Failure Review.

More info

Less info

Register now

Target Audience

  • Heart Failure Specialists
  • General Cardiologists
  • General Practitioners (GPs)
  • Nurses, Pharmacists, and other Allied Healthcare Professionals

Learning Objectives

Following the activities, participants will be able to:

  • Select foundational and advanced management strategies in complex patients
  • Discuss the validity of using ejection fraction to determine optimal treatment strategies
  • Assess the likely impact of health technology on future practice
  • Identify the underlying causes of heart failure
  • Select appropriate interventional and device-based treatments for treating underlying causes of heart failure
  • Assess the impact of the multidisciplinary team on heart failure outcomes
  • Discuss the importance of using quality of life and patient self-assessed measures relative to hard clinical end points

If you’re interested in becoming an educational partner or sponsor at HFO, please contact

Official Journal


Cardiac Failure Review (CFR) is an international, English language, peer-reviewed journal that publishes articles continually to and aims to assist time-pressured physicians to stay abreast of key advances and opinion in the area of heart failure.

The journal comprises balanced and comprehensive review articles written by leading authorities. The journal provides updates on a range of salient issues to support physicians in developing their knowledge and effectiveness in day-to-day clinical practice.

The journal endeavours to support the continuous medical education of specialist and general cardiologists and disseminate knowledge of the field to the wider cardiovascular community.

Led by Editor-in-Chief, Prof Andrew Coats, along with Deputy Editor in Chief, Giuseppe Rosano and Associate Editor Christiana Vitale and an editorial board of world-renowned physicians, the Journal publishes peer-reviewed articles that aim to provide timely updates on the most pertinent issues in the field.

View the latest volume of CFR.


About Radcliffe Cardiology

Through our evidence-based and peer-reviewed content, we adhere to the highest editorial standards to showcase the best in research insight and innovation. From great science writing and smart journal editing to engaging new formats that cut through the noise. From relatable presenters at the heart of the profession to interactive learning programmes that fit with your career... we bring medical education to life.

We're here to bring medical knowledge, insight and innovation to life for vascular and endovascular clinicians around the world, using our communications and creative expertise, our platforms and connections across the community to help transform theory into practice faster and more effectively.

We believe that great communication is at the heart of great healthcare. Powerful research and ingenious innovation have always fuelled progress in health but it's the way that new ideas are shared that ensures positive change happens quickly and equitably. For us, this is always a blend of the medium and the message – where, when and how important knowledge is communicated.

For more information on Radcliffe Cardiology, please visit